Park, Tanya, and Workun, Bernadette (2015) Further evidence to support weight loss and lifestyle interventions for people taking antipsychotic medications. Evidence Based Mental Health, 18. p. 128.

PDF (Published Version) - Published Version Restricted to Repository staff only

Abstract

Increasing weight is the leading risk factor for many life-shortening illnesses such as cardiovascular disease, stroke and diabetes.1 Individuals with serious mental illness (SMI) such as schizophrenia are at increased risk of medical comorbidities, including metabolic syndrome, leading to an increased risk for cardiovascular disease and diabetes. As a result, life expectancy is shorter than those in the general population.2 The elevated cardiometabolic risks can be due to inadequate nutrition, limited access to medical care, sedentary lifestyle, smoking and treatments such as prescription of antipsychotic medications. Healthy lifestyle interventions developed specifically for people with mental illness are essential in the treatment and prevention of reduction of weight gain and risk of diabetes.

Item ID:	82336
Item Type:	Article (Commentary)
ISSN:	1362-0347
Copyright Information:	Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions
Date Deposited:	25 Jun 2024 01:25
FoR Codes:	42 HEALTH SCIENCES > 4205 Nursing > 420504 Mental health nursing @ 100%
SEO Codes:	20 HEALTH > 2004 Public health (excl. specific population health) > 200409 Mental health @ 100%
	More Statistics